
Dec 15 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O:
AMPHASTAR PHARMACEUTICALS INC: FDA APPROVAL FOR TERIPARATIDE INJECTION
AMPHASTAR PHARMACEUTICALS: FDA DETERMINED THAT CO'S TERIPARATIDE IS BIOEQUIVALENT & THERAPEUTICALLY EQUIVALENT TO ELI LILLY'S FORTEO
AMPHASTAR PHARMACEUTICALS INC: PLANS TO LAUNCH ITS TERIPARATIDE INJECTION BY END OF YEAR